Bb Biotech Ag
Basic Stats
Market Value
3.98B
Top 10 (%)
64.7%
Portfolio Size (Change from Prev.)
35 (1)
Avg. Holding Period
13 years
Turnover
0.1%
Industry Breakdown
Pharmaceutical Preparations
65.4%
Biological Products, (no Diagnostic Substances)
23.3%
Services-commercial Physical & Biological Research
7.8%
Ticker | Company | Market Value | % Portfolio | Shares | Chg. Shares % | Chg. Shares | Quarter End Price | % Owned |
|---|---|---|---|---|---|---|---|---|
 IONS | Ionis Pharmaceuticals Inc. | 627.04M | 15.8% | 7.7M | -11.6% | -1.0M | 81.00 | 5.6% |
 INCY | Incyte Corp. | 311.36M | 7.8% | 3.6M | -4.9% | -188.3K | 86.00 | 1.7% |
 NBIX | Neurocrine Biosciences Inc. | 296.61M | 7.5% | 3.4M | 0.7% | 23.7K | 89.00 | 3.7% |
 VRTX | Vertex Pharmaceuticals Inc | 239.14M | 6.0% | 1.3M | -5.1% | -70.4K | 186.00 | 0.5% |
 SAGE | Sage Therapeutics, Inc. | 218.73M | 5.5% | 1.4M | — | — | 158.00 | 2.8% |
 CELG | Celgene Corp | 207.55M | 5.2% | 2.2M | -4.5% | -103.9K | 94.00 | 0.3% |
 AGIO | Agios Pharmaceuticals, Inc. | 200.85M | 5.0% | 3.0M | 3.5% | 100.0K | 64.00 | 5.1% |
 ALXN | Alexion Pharmaceuticals, Inc. | 177.68M | 4.5% | 1.3M | — | — | 135.00 | 0.6% |
 ALNY | Alnylam Pharmaceuticals, Inc. | 152.43M | 3.8% | 1.6M | 3.8% | 59.7K | 92.00 | 1.5% |
 ESPR | Esperion Therapeutics, Inc. | 141.45M | 3.6% | 3.5M | 3.8% | 130.0K | 40.00 | 13.1% |
 RDUS | Radius Health, Inc. | 135.23M | 3.4% | 6.8M | 1.1% | 71.4K | 25.00 | 24.5% |
 HALO | Halozyme Therapeutics Inc. | 134.00M | 3.4% | 8.3M | — | — | 16.00 | 5.8% |
 ARGX | Argenx Se | 112.95M | 2.8% | 904.7K | 2.3% | 20.0K | 127.00 | 2.4% |
 MRNA | Moderna, Inc. | 97.39M | 2.4% | 4.8M | — | — | 21.00 | 1.5% |
 MYOV | Myovant Sciences Ltd. | 85.88M | 2.2% | 3.6M | — | — | 24.00 | 5.4% |